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Proximal tubular basement membrane width in insulin-dependent
diabetes mellitus. Although glomerular structure has been studied, careful
evaluation of tubular basement membrane (TBM) structure in diabetes in
humans has not been done. We measured proximal TBM width, glomer-
ular basement membrane (GBM) width, mesangial fractional volume
[Vv(Mes/glom)], mesangial matrix fractional volume [Vv(MM/glom)], and
cortical interstitial fractional volume [Vv(Int/cortex)] in 35 insulin-depen-
dent diabetic (IDDM) patients and 20 controls. The patients’ mean age
was 28 6 10 years (X# 6 SD) and IDDM duration was 17 6 8 years.
Twenty-five patients were normoalbuminuric, four microalbuminuric, and
six had overt proteinuria. Tubular basement membrane and GBM widths
were measured by the orthogonal intercept method and mesangial and
interstitial parameters by point counting. The TBM width was 915 6 320
nm in IDDM patients and 558 6 116 nm in controls (P 5 0.0005); the
TBM width was also increased in normoalbuminuric patients (849 6 297
nm, P 5 0.0005). The TBM width was strongly directly related to GBM
width (r 5 0.67, P , 0.001), Vv(Mes/glom) (r 5 0.52, P , 0.01), and
Vv(MM/glom) (r 5 0.61, P , 0.001), but only weakly to Vv(Int/cortex)
(r 5 0.29, NS). The TBM width (r 5 0.65, P , 0.001) and GBM width (r 5
0.65, P , 0.001) were strongly related to hemoglobin A1C (HbA1C), while
the Vv(Mes/glom) (r 5 0.35, P , 0.05) and Vv(Int/cortex) (r 5 0.30, NS)
were only weakly related to HbA1C. Thus, increased proximal TBM width
is an integral component of early nephropathology in IDDM patients. This
study suggests that the metabolic disturbances of diabetes are strong
determinants of the constellation of structural abnormalities occurring in
human diabetic nephropathy.
Diabetic nephropathology is characterized by glomerular, vas-
cular, tubular, and interstitial lesions that initially develop in the
absence of measurable renal dysfunction [1]. Lesions progress so
slowly in most type I insulin-dependent diabetic (IDDM) patients,
that they escape clinically significant renal disease [2, 3]. However,
in approximately 25% of patients, the rate of development of
these lesions is sufficiently rapid so as to result in renal functional
changes after one or more decades of IDDM [4]. These functional
changes then progress at variable rates towards end-stage renal
failure [5].
Glomerular lesions include thickening of the glomerular base-
ment membrane (GBM) [1, 6] and increase in the volume fraction
of the glomerulus occupied by mesangium [Vv(Mes/glom)] [1, 6],
especially the mesangial matrix (MM) component [6, 7]. Eventu-
ally, the increasing Vv(Mes/glom) becomes associated with a
decreased peripheral glomerular capillary filtration surface, and
this is highly correlated with a decrease in glomerular filtration
rate (GFR) [8, 9]. A decline in kidney function in diabetic
nephropathy is also associated with interstitial expansion [10, 11]
and with an increase in the percent of globally sclerotic (GS)
glomeruli [12, 13]. These latter two structural changes, however,
appear to be functionally important only at the later stages of the
disease [10, 12]. The disease is also associated with hyalinosis
lesions of afferent and efferent glomerular arterioles [1, 12],
which, if severe, are closely related to GS [12].
Thus, diabetic nephropathy in a broad sense is consequent to
the accumulation of renal extracellular matrix, particularly within
the glomerulus [7, 14, 15] and, ultimately, in the renal interstitium
[10, 15]. It is important in the understanding of the pathogenesis
of this disorder to know if all renal basement membranes are
involved in this process. Although tubular basement membrane
(TBM) thickening and reduplication accompanies tubular atrophy
at the advanced stages of diabetic nephropathy [10], very little is
known of the changes in this structure at the earlier stages of
disease. Thus, although morphometric studies of glomerular
structures have been performed in diabetes, the ultrastructure of
the tubules has not been adequately explored. Proximal TBM
width has been measured only in a study of nine pairs of identical
twins discordant for IDDM [2]. The TBM width was consistently
greater in the diabetic compared to the non-diabetic twins, but
normal values were not reported, and the number of IDDM
patients studied was too small for relationships of TBM width to
other renal structures or to renal function to be evaluated.
The present study measured proximal TBM width in 35 IDDM
patients and is the first report evaluating interrelationships of this
parameter to other renal structural parameters, to renal function
and to glycemic control. The TBM width was increased in IDDM,
even among the normoalbuminuric patients. Tubular basement
membrane width in IDDM patients was strongly correlated with
GBM width and Vv(Mes/glom) but only weakly with the volume
fraction of renal cortex that is interstitium [Vv(Int/cortex)]. Glo-
merular basement membrane and TBM width were more closely
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correlated with glycosylated hemoglobin (HbA1C) than other
renal structural measures.
METHODS
Patients
We studied 35 patients (24 female), age 28 6 10 (X# 6 SD), with
a duration of diabetes of 17 6 8 years. Fifteen patients had renal
biopsies done as part of an evaluation for consideration for
pancreas transplantation, nine were part of a study of renal
structure and function in IDDM siblings pairs and 11 were part of
a study of the natural history of nephropathy in IDDM. Data on
glomerular structure in 11 of the 15 prepancreas transplant
patients have previously been reported [3]. Patients were selected
if they had Vv(Mes/glom) values ranging from normal to moder-
ately advanced. Twenty-five of the 35 patients selected were
normoalbuminuric because a primary purpose of this investigation
was to evaluate TBM changes at the earlier stages of disease. No
other selection criteria were used. Twenty normal controls (14
female), age 26 6 8 years were selected from available biopsies of
renal transplant donors obtained at the time of transplant surgery.
Controls were matched with IDDM patients for age and gender.
All studies were approved by the Human Subjects Committees of
the relevant institutions. All the IDDM patients gave written
informed consent before the study. Living related donors also
provided informed consent for renal biopsies, but consent was not
obtained in the case of cadaver donors.
Clinical studies
Estimates of glomerular filtration rate (GFR) by creatinine
clearance (CCr) and albumin excretion rate (AER) on the pre-
pancreas transplant patients and IDDM sibling pairs were based
on multiple (at least 3) carefully supervised inpatient 24-hour
urine collections as described elsewhere [1, 8]. We have previously
reported an excellent correlation between this CCr method and
inulin clearance in similar patients (r 5 0.85, P , 0.0001) [8]. The
other patients had multiple timed overnight urine collections for
AER and GFR estimated by continuous iothalamate infusions
with four timed urine collection periods.
Blood pressure was determined as the mean of multiple read-
ings by trained personnel using automated equipment. Hyperten-
sion was defined as systolic blood pressure (sBP) $ 135 or
diastolic BP (dBP) $ 85 mm Hg, according to the criteria of the
Joint National Committee on the Detection, Evaluation, and
Treatment of High Blood Pressure or BP . 2 SD above normal for
age for children [16, 17].
Serum and urinary creatinine levels were measured by an
automated kinetic method that uses the Jaffe´ reaction. Urine and
plasma iothalamate concentrations were measured by high pres-
sure liquid chromatography (HPLC). Normal values for GFR are
90 to 130 ml/min/1.73 m2. Albumin excretion rate (AER) was
measured by nephelometry using the Beckman kit (Beckman,
Fullerton, CA, USA) or by a fluorimetric method [18]. Microalbu-
minuria was defined as values between 20 and 200 mg/min. HbA1C
was measured at the time of biopsy by HPLC using the BioRad
Diamat System (Bio-Rad, Hercules, CA, USA).
Renal structural studies
Renal tissue was obtained by percutaneous biopsy and was
processed for light and electron microscopy as previously de-
scribed [1, 3]. All morphometric measurements were performed
without knowledge of the patient’s identity.
Electron microscopic examination was conducted on tissue
fixed in 2.5% glutaraldehyde in Millonig buffer and embedded in
Polybed 812 (Polysciences, Warrington, PA, USA). Sections 1 mm
thick were cut and stained with toluidine blue to permit random
selection of the centermost, intact glomeruli at least one tubular
diameter from the edge of the tissue block [1, 3]. Globally
sclerotic glomeruli were excluded. At least three glomeruli were
analyzed from each biopsy. Ultrathin sections were obtained and
examined with a JEOL JEM-100 CX electron microscope (JEOL,
Tokyo, Japan). Glomeruli were photographed and printed at a
magnification of 33,900 to produce photomontages of the entire
glomerular profile, defined as the circumscribed, minimal convex
polygon enclosing the glomerular tuft [3]. The montages were
used to estimate Vv(Mes/glom), superimposing a double lattice
square grid with equally spaced coarse points 60 mm apart and
equally spaced fine points 30 mm apart, so that each coarse point
represents four fine points. Vv(Mes/glom) was estimated by
counting the number of fine points falling on mesangium (FPm)
(including its matrix and cellular components and the GBM lying
between the epithelial cells and the mesangium) in relation to the
number of coarse points hitting the glomerular tuft (CPg) [3].
Because each coarse point represents four fine points, then
Vv~Mes/glom! 5
FPm
CPg 3 4
The transition between the peripheral capillary area and the
mesangium was determined on the basis of the widening of the
distance and disappearance of the parallelism between the endo-
thelial and epithelial cells [1]. This demarcation was used to
identify the beginning of the mesangium as well as the end of the
peripheral glomerular basement membrane (PGBM). There was
an average of 322 6 123 course points per biopsy for this measure
in controls and 223 6 60 in IDDM patients. The normal value in
the control subjects for Vv(Mes/glom) was 0.21 6 0.03 in this
study and 0.20 6 0.03 in earlier studies with larger numbers of
subjects [3].
Another set of photomicrographs, obtained at 312,000 by
entering the glomerulus at its lowest segment and systematically
sampling ' 20% of the glomerular profile, was used to obtain
GBM width. Glomerular basement membrane width was esti-
mated by the orthogonal intercept method [3]. There were 242 6
107 intercepts obtained for control values and 151 6 58 for values
for IDDM patients. The normal value in the control subjects was
334 6 38 nm. The volume fraction of mesangial matrix per
glomerulus [Vv(MM/glom)] and Vv mesangial cell per glomerulus
[Vv(MC/glom)] were estimated by the point counting technique
on the high magnification photographs [7]. Points falling on
mesangial cell (PMC), mesangial matrix (PMM), and mesangial
GBM (PMGBM) were noted. Calculations are as follows:
Vv~MC/mes! 5
PMC
PMC 1 PMM 1 PMGBM
Vv~MM/mes! 5
PMM
PMC 1 PMM 1 PMGBM
Vv~MC/glom! 5 Vv~MC/mes! 3 Vv~Mes/glom!
Vv~MM/mes! 5 Vv~MM/mes! 3 Vv~Mes/glom!
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Proximal tubular basement membrane width was estimated as
follows. The proximal segment of the proximal tubule (PSPT) was
identified by the structural characteristics of the tubular epithelial
cells. Epithelial cells of the proximal segment of the proximal
tubule are tall columnar cells with well developed brush borders
and elongated mitochondria [19]. Atrophic tubules were not
studied. Tissue sections were entered at the upper left corner and
the microscope stage controls moved systematically such that
fields an equal distance apart were examined over the entire
section for the presence of a PSPT. The PSPT TBM so encoun-
tered were then photographed and the micrographs were printed
at a final magnification of 312,000. A calibration grid was also
photographed and used to determine the precise magnification. A
grid with perpendicular line segments was superimposed over
each micrograph (Fig. 1). When a grid line intersected the
TBM-tubular epithelial cell interface, a harmonic ruler with
classes equidistant on a log reciprocal scale was used to ascertain
the orthogonal width of TBM [20]. Since these methods were
primarily used on electron microscopy blocks initially trimmed for
the study of glomeruli, only tubules within 2 to 3 tubular diameters
from glomeruli were studied. Two to three blocks which included
60 to 100 tubular profiles per patient were evaluated. A total of
159 6 62 intercepts were used to obtain values for controls and
228 6 78 for values for IDDM patients. The mean value for TBM
width in the control subjects was 558 6 116 nm.
Tissue for light microscopic analysis was embedded in paraffin,
cut in 5 mm thick sections, and stained with periodic acid-Schiff
(PAS). Vv(Int/cortex) was estimated using a projecting micro-
scope at a magnification of 3300 [10]. All available cortical tissue
on a single section was measured. Points falling on the intersti-
tium, defined as the space outside Bowman’s capsule, tubular
basement membrane and vessels larger than one tubular diame-
ter, and total number of points overlying the cortical tissue were
counted to estimate the Vv(Int/cortex), using a 1:4 grid with a
distance between fine points of 13 mm (normal value, 0.08 6
0.03).
Statistical analyses
Data are expressed as mean 6 1 SD, except for AER where the
median and range are given. Because they were not normally
distributed, values for AER were logarithmically transformed
before analysis. Comparisons between the diabetic patients and
the controls were performed using Student’s t-tests for unpaired
data. The relationships between functional and structural param-
eters and relationships to glycemia were analyzed by linear
regression analysis. In addition, multiple linear regression analysis
was used to assess the relationship between the structural out-
come variables and HbA1C, adjusted for IDDM duration. This
analysis allowed estimates of the independent contribution of
glycemia and duration on the renal structural measures. Values
for P , 0.05 were considered significant.
RESULTS
Clinical characteristics
The GFR in the IDDM patients was 104 6 32 (46 to 193)
ml/min/1.73 m2 [X# 6 SD (range)]. Twelve patients had GFR
values , 90 ml/min/1.73 m2. The AER was 8 (0.4 to 3492) mg/min
[median (range)]. Twenty-five patients were normoalbuminuric
(AER , 20 mg/min), four were microalbuminuric (AER 20 to 200
mg/min), and six had overt nephropathy. Hypertension was
present in five of 35 patients.
Structural comparisons in patients and controls
All structural measures were increased in IDDM patients
compared to controls except for Vv(MC/glom), which was virtu-
ally identical in the two groups (Table 1). The same was true when
normoalbuminuric patients were analyzed separately (Table 1).
Moreover, 18 patients had normal AER, GFR, and blood pres-
sure (BP). This subset, compared to controls, also had an in-
creased GBM width (P , 0.001), TBM width (P , 0.005),
Vv(Mes/glom) (P , 0.025), Vv(MM/glom) (P , 0.025), and
Vv(Int/cortex) (P , 0.001).
Structural interrelationships
The duration of IDDM was directly correlated with Vv(Mes/
glom) (r 5 0.50, P , 0.01) and Vv(MM/glom) (r 5 0.50, P , 0.01),
more weakly with TBM width (r 5 0.34, P , 0.05) and Vv(Int/
cortex (r 5 0.29, NS), but not with GBM width (r 5 0.14, NS) or
Vv(MC/glom) (r 5 0.08, NS). There were no significant correla-
tions among these structural variables in the controls.
Tubular basement membrane width in IDDM patients was
directly and strongly correlated with GBM width (r 5 0.67, P ,
0.001; Fig. 2), Vv(Mes/glom) (r 5 0.52, P , 0.01; Fig. 3) and
Vv(MM/glom) (r 5 0.53, P , 0.001), but was only weakly
correlated with Vv(Int/cortex) (r 5 0.32, NS), and not related to
Vv(MC/glom) (r 5 0.05, NS). Glomerular basement membrane
width and Vv(Mes/glom) were also strongly directly correlated
(r 5 0.66, P , 0.001) and both were strongly correlated with
Vv(Int/cortex) (r 5 0.56 and 0.61, respectively, P , 0.001 in both
instances).
Considering the possibility that systemic hypertension might
directly influence glomerular lesions without directly affecting the
severity of TBM abnormalities the regression analyses were
repeated with only the normotensive IDDM patients. The corre-
lation between TBM and GBM widths (r 5 0.70, P , 0.0001; Fig.
2) was similar to that seen when all patients were considered (see
above), but the correlation of TBM width and Vv(Mes/glom) was
stronger without the hypertensive patients (r 5 0.70, P , 0.001;
Fig. 3).
Structural functional relationships
Log AER was more closely correlated with glomerular struc-
tural measures including Vv(Mes/glom) (r 5 0.78, P , 0.001),
Vv(MM/glom) (r 5 0.84, P , 0.001) and GBM width (r 5 0.68,
P , 0.001) than with Vv(Int/cortex) (r 5 0.60, P , 0.001, N 5 33)
or TBM width (r 5 0.42, P , 0.05).
Glomerular filtration rate was most closely inversely correlated
to Vv(Mes/glom) (r 5 20.64, P , 0.001) and was less precisely
inversely correlated with GBM (r 5 20.46, P , 0.01) or TBM
width (r 5 20.54, P , 0.001). There was no correlation of GFR
with Vv(Int/cortex) (r 5 0.01, NS) in these IDDM patients.
Fourteen IDDM patients had TBM width measurements within
the normal range. Twelve of these 14 patients also had normal
VV(Mes/glom), 7 had normal GBM width, and 5 had normal
VV(Int/cortex). The AER was normal in 11 of these 14 patients
while one had microalbuminuria and two had overt nephropathy.
Three of these 14 patients had reduced GFR and one was
hypertensive.
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Glycemia and structure
GBM width and TBM width were more strongly directly related
to HbA1C (r 5 0.65 and 0.65, respectively; P , 0.001 for each)
than were Vv(Mes/glom) (r 5 0.35, P , 0.05), Vv(MM/glom) (r 5
0.37, P , 0.05), or Vv(Int/cortex) (r 5 0.30, NS). Since the
duration of disease varied among the IDDM patients, multiple
regression analysis was performed in order to estimate the
contribution of glycemia to the renal structural measures, inde-
pendent of duration. Adjusted for duration, an increment in
HbA1C of 1% was associated with an increase TBM width of 60.2
Fig. 1. Electron microscopic photomicrograph of a representative proximal segment of a proximal tubule in a control subject illustrating the tubular
epithelial cells with long microvilli (MV) and prominent mitochondria (M). Additional abbreviations are: TBM, tubular basement membrane; L,
tubular lumen. The grid used for these studies is superimposed on the photomicrograph (311,000).
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nm (P , 0.001; Table 2), while an increase in duration of one year
was estimated to increase TBM width by 10.3 nm (P 5 0.033;
Table 2). The GBM width was significantly influenced by HbA1C
but not by duration in this study, while Vv(Mes/glom) appeared to
be influenced by both variables, but statistically more strongly by
duration (Table 2). A similar trend is seen for Vv(MM/glom)
(Table 2). Neither HbA1C nor duration affected Vv(MC/glom)
and Vv(Int/cortex) (Table 2).
DISCUSSION
The changes in TBM structure in IDDM and the relationship of
these changes to other renal structural changes, renal function,
and to clinical parameters of glycemia and IDDM duration have
not been previously studied. This study shows that thickening of
the proximal TBM is an integral component of the constellation of
renal lesions seen in IDDM patients. The TBM of the proximal
tubule was selected for study because of the relative ease of
identification of this structure [20], thus providing consistency of
comparisons within and between groups. Although the TBM
width at other levels of the tubule was not addressed, it would not
be surprising, given the concordances found between the various
renal structures studied here, that TBM thickening is a general-
ized process along the tubule among many IDDM patients.
Nevertheless, further studies of other tubular segments would be
helpful, particularly in relationship to the variations in extracel-
lular matrix composition of the TBM at different levels of the
nephron [21].
Patients were selected who were mostly at earlier stages of
diabetic nephropathy (25 of 35 were normoalbuminuric, 23 had
normal GFR, and 30 were normotensive) in order to avoid the
more advanced changes of diabetic nephropathy with increasing
severity of global glomerulosclerosis and vascular disease and
associated interstitial fibrosis, tubular atrophy, and marked focal
tubular basement thickening and reduplication [10–12]. Also,
although rarely encountered, TBMs of atrophic tubules, a priori,
were not measured. Thus, it is reasonable to conclude that the
changes in TBM width in this study were directly consequent
to the diabetic state and not secondary to advanced nephron
Table 1. Structural comparisons of IDDM patients and controls
TBM width
GBM
width
Vv(Mes/glom) Vv(MM/glom) Vv(MC/glom) Vv(Int/cortex)nm
IDDM patients (N 5 35) 915 6 320 528 6 172 0.30 6 0.10 0.16 6 0.08 0.09 6 0.03 0.20 6 0.07
Number of patients with normal values 14/35 11/35 16/35 10/32 30/32 9/33
NA IDDM patients (N 5 25) 849 6 297 460 6 128 0.26 6 0.06 0.13 6 0.04 0.09 6 0.03 0.18 6 0.06
Controls (N 5 20) 558 6 116 334 6 38 0.21 6 0.03 0.09 6 0.01 0.09 6 0.02 0.08 6 0.03
All IDDM vs. controls (P values) 0.0005 0.0005 0.0005 0.0005 NS , 0.001
NA IDDM vs. controls (P values) 0.0005 , 0.0005 , 0.0005 0.0005 NS , 0.001
Abbreviations are: IDDM, insulin-dependent diabetes mellitus; N, number of patients studied; NA, normoalbuminuria; TBM, tubular basement
membrane; GBM, glomerular basement membrane; Vv(Mes/glom), volume fraction (mesangium/glomerulus); Vv(MM/glom), Vv(mesangial matrix/
glomerulus); Vv(MC/glom), Vv(mesangial cell/glomerulus); Vv(Int/cortex), Vv(interstitium/cortex); NS, not significant.
Fig. 2. Relationship of tubular basement membrane (TBM) width and
glomerular basement membrane (GBM) width in the IDDM patients: (F)
normotensive patients; (E) hypertensive patients; r 5 0.67, P < 0.001.
Fig. 3. Relationship of tubular basement membrane (TBM) width and
mesangial fractional volume [Vv(Mes/glom)] in the IDDM patients: (F)
normotensive patients; (E) hypertensive patients; r 5 0.52, P < 0.01.
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damage. This is further evidenced by the strong direct correlations
of TBM width with glomerular measures of diabetic nephropathy
and with glycemia.
Glomerular basement membrane thickening is the earliest
detectable glomerular structural change in IDDM patients [6],
perhaps reflecting the precision with which this parameter can be
measured. An increase in Vv(Mes/glom) takes longer to become
detectable [6], is more closely related to renal functional distur-
bance in cross-sectional studies [1, 3, 9], and is the only renal
structural parameter correlated with increasing AER in longitu-
dinal studies [25]. Nonetheless, GBM width, Vv(Mes/glom) [1, 3]
and as shown here, TBM width are all significantly correlated to
each other and, in these cross sectional analyses, to renal func-
tional disturbances. Nonetheless this study, which includes mea-
surements of TBM width, confirms previous studies measuring
only glomerular parameters [3] in finding that long-standing
IDDM patients with normal functional measures (AER, GFR,
and BP) have, on average, abnormal renal structural measures.
Thus, substantial renal structural changes in IDDM can occur
without clinical warning.
The lack of significant correlations between the measures of
glomerular, tubular or interstitial structures among the normal
controls is consistent with the idea that changes measured in
diabetic patients are largely the consequence of the diabetic state
rather than an exaggeration of inherent structural characteristics
within the kidney. The precision of the correlations of proximal
TBM width with GBM width and with Vv(Mes/glom) were similar
to that of Vv(Mes/glom) and GBM width to each other, indicating
that these structural changes are occurring in IDDM patients
roughly in parallel. Further, TBM width was correlated with
Vv(MM/glom) but not with Vv(MC/glom), consistent with the
idea that the TBM changes are part of a broad accumulation of
basement membrane extracellular matrix material in the diabetic
kidney. These findings are also compatible with previous studies
indicating that mesangial expansion in patients with long-standing
IDDM is mainly due to mesangial matrix accumulation [7]. The
present study is also consistent with earlier findings that GBM and
mesangial changes may occur at different rates within the same
IDDM patients, perhaps reflecting somewhat different influences
of the diabetic state on specific renal cells and extracellular
matrices [1, 22].
Further, these results indicate that TBM thickening and inter-
stitial expansion are not closely related. These findings suggest
that, at earlier stages of the disease, diabetes differentially affects
cells responsible for the production of basement membrane
extracellular matrix (ECM) molecules that compose TBM as
contrasted with interstitial extracellular matrix (largely collagens I
and III) [23]. At later stages of various renal diseases, including
diabetic nephropathy, the interstitium shows increases in both
basement membrane and non-basement membrane ECM pro-
teins (collagens I and III) [24, and Y. Kim, unpublished observa-
tions]. Nonetheless, as previously shown [10] and confirmed here,
interstitial expansion in diabetic nephropathy is correlated with
diabetic glomerular structural changes including GBM widening
and mesangial expansion. However, studies of sequential biopsies
in IDDM patients found increasing urinary albumin excretion
rates in association with increasing mesangial expansion, while
interstitial measures remained stable [25]. This study and the
current study provide support to the hypothesis that the renal
cortical interstitial changes in diabetes may be secondary to
advanced glomerular and vascular and tubular lesions, and not
primary to the processes of the development of the earlier stages
of diabetic renal disease. This is confirmed in the present study in
which both AER and GFR were more closely related to mesangial
measures than to other structural parameters.
Environmental factors are important in influencing the rate of
development of the individual lesions of diabetic nephropathy. A
number of lines of evidence, including natural history studies [26,
27] and intervention trials [28, 29], indicate that glycemia is a key
variable and that genetic predisposition to nephropathy risk may
be particularly expressed in patients with poor glycemic control
[30]. This study found that a number of renal structural variables,
particularly TBM and GBM widths, are correlated with glycemia
as estimated by HbA1C values obtained around the time of renal
biopsy. Although also influenced by glycemia, mesangial param-
eters were more strongly influenced by IDDM duration. Contrast-
ing with these glomerular measures, at these earlier stages of
diabetic nephropathy cortical interstitial fractional volume, ad-
justed for duration, was not related to glycemia and this is
consistent with studies (see above) arguing that interstitial
changes in IDDM are, at least in part, consequent to the
development of other diabetic lesions and may have a different
pathogenetic basis.
Considering other “environmental” factors, we examined the
possibility that systemic hypertension could influence glomerular
and tubular structural parameters differently. The improvement
in the precision of correlation between TBM width and Vv(Mes/
glom) when patients with systemic hypertension were eliminated
from the analysis supports the concept that systemic hypertension
could influence glomerular lesions; however, the small number of
patients with hypertension in the current study was insufficient to
draw any firm conclusions.
The present studies confirm earlier observations indicating that
normoalbuminuric long-standing IDDM patients as a group often
have glomerular, tubular and interstitial structural abnormalities
[3], although many normoalbuminuric individuals have measure-
ments in each structural category that are still within the normal
range.
It has been hypothesized that glomerular hemodynamic abnor-
malities of diabetes are causally related to the development of the
early lesions in diabetic glomerulopathy [31, 32]. Evidence to
Table 2. Association between morphometric parameters and HbA1C,
adjusted for duration
Morphometric
parameter
Parameter estimates
HbA1C P value Duration P value
TBM width nm 60.2 0.001 10.3 0.033
GBM width nm 36.7 0.001 2.5 NS
Vv(Mes/glom) 0.01 0.013 0.004 0.005
Vv(MM/glom) 0.01 0.075 0.004 0.006
Vv(MC/glom) 20.001 NS 0.0004 NS
Vv(Int/cortex) 0.006 NS 0.004 NS
Abbreviations are: HbA1C, hemoglobin A1C; TBM, tubular basement
membrane; GBM, glomerular basement membrane; Vv(Mes/glom), vol-
ume fraction (mesangium/glomerulus); Vv(MM/glom), Vv(mesangial ma-
trix/glomerulus); Vv(MC/glom), Vv(mesangial cell/glomerulus); Vv(Int/
cortex), Vv(interstitium/cortex); NS, not significant.
Brito et al: Tubular basement membrane width in diabetes 759
support this idea has largely been derived from studies demon-
strating amelioration of the structural end-point of focal segmen-
tal glomerulosclerosis (FSGS) and the functional end-point of
proteinuria in diabetic rats treated with angiotensin converting
enzyme inhibition (ACEI) [33] or low protein diet [34], both of
which normalized glomerular capillary hypertension in these
animals. However, FSGS is not a typical lesion in diabetic
nephropathy in humans [1]. Further, ACEI treatment failed to
influence GBM width or Vv(Mes/glom) in diabetic rats, although
this treatment did prevent the increase in urinary albumin excre-
tion rate in these animals [35]. The results of the present study
also argue against the concept that glomerular hemodynamic
abnormalities are important for the genesis of the early specific
lesions of diabetic nephropathy. The increase in proximal TBM
width is highly correlated with the GBM and mesangial changes of
the disease. Yet, it is difficult to envision how glomerular hemo-
dynamic abnormalities could directly influence TBM structure.
Further studies in diabetic rats have demonstrated normal tubular
luminal pressures [31]. It is more likely that the TBM, GBM and
mesangial structural abnormalities are primarily due to the met-
abolic arrangement of the diabetic state. However, this argument
does not negate the possibility that once the renal lesions of
diabetes are far advanced, the rate of progression of the disease
towards end-stage renal failure may be greatly influenced by renal
hemodynamic abnormalities [36, 37].
In summary, TBM thickening is an early abnormality in IDDM
antedating, although not necessarily leading to, renal functional
abnormalities and is correlated with glomerular changes of GBM
thickening and mesangial expansion but not with interstitial
expansion. TBM and GBM thickening are both sensitive indica-
tors of the severity of hyperglycemia. These findings strongly
support a metabolic basis for these renal structural abnormalities
of diabetic nephropathy and suggest that studies of proximal
tubular cell responses to hyperglycemia could provide useful
insights into the pathogenesis of this important cause of end-stage
renal disease.
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APPENDIX
Abbreviations used in this article are: AER, albumin excretion rate; CCr,
creatinine clearance; CPg, number of coarse points hitting the glomerular
tuft; dBP, diastolic blood pressure; FPm, number of fine points falling on
mesangium; GBM, glomerular basement membrane; GFR, glomerular
filtration rate; GS, glomerular sclerosis; HbA1C, hemoglobin A1C; HPLC,
high pressure liquid chromatography; IDDM, insulin-dependent diabetes
mellitus; MM, mesangial matrix; NS, not significant; PAS, periodic
acid-Schiff; PGBM, peripheral glomerular basement membrane; PSPT,
proximal segment of proximal tubule; TBM, tubular basement membrane;
sBP, systolic blood pressure; Vv(Int/cortex), volume fraction of interstiti-
um/cortex; Vv(MC/glom), volume fraction of mesangial cell/glomerulus;
Vv(Mes/glom), volume fraction of mesangium per glomerulus; Vv(MM/
glom), volume fraction of mesangial matrix/glomerulus.
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